Search tips
Search criteria 


Logo of bmcbiocBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Biochemistry
BMC Biochem. 2011; 12: 57.
Published online Nov 4, 2011. doi:  10.1186/1471-2091-12-57
PMCID: PMC3240831
Differential pattern of glycogen accumulation after protein phosphatase 1 glycogen-targeting subunit PPP1R6 overexpression, compared to PPP1R3C and PPP1R3A, in skeletal muscle cells
Marta Montori-Grau,corresponding author1,2 Maria Guitart,1,2 Cèlia García-Martínez,1,3 Anna Orozco,1,2 and Anna Maria Gómez-Foix1,2
1CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Pg de la Bonanova 69, 6a planta, 08017-Barcelona, Spain
2Departament de Bioquímica i Biologia Molecular, IBUB, Facultat de Biologia, Universitat de Barcelona, Diagonal 643, 08028-Barcelona, Spain
3Departament de Patologia i Terapèutica Experimental, Unitat organitzativa Bellvitge, Universitat de Barcelona, Pavelló de Govern, Pl. 5a, Feixa Llarga, S/N, 08907-Hospitalet de Llobregat, Spain
corresponding authorCorresponding author.
Marta Montori-Grau: mmontori/at/; Maria Guitart: maguita022002/at/; Cèlia García-Martínez: celiagarcia/at/; Anna Orozco: aorozco/at/; Anna Maria Gómez-Foix: agomezfoix/at/
Received March 25, 2011; Accepted November 4, 2011.
PPP1R6 is a protein phosphatase 1 glycogen-targeting subunit (PP1-GTS) abundant in skeletal muscle with an undefined metabolic control role. Here PPP1R6 effects on myotube glycogen metabolism, particle size and subcellular distribution are examined and compared with PPP1R3C/PTG and PPP1R3A/GM.
PPP1R6 overexpression activates glycogen synthase (GS), reduces its phosphorylation at Ser-641/0 and increases the extracted and cytochemically-stained glycogen content, less than PTG but more than GM. PPP1R6 does not change glycogen phosphorylase activity. All tested PP1-GTS-cells have more glycogen particles than controls as found by electron microscopy of myotube sections. Glycogen particle size is distributed for all cell-types in a continuous range, but PPP1R6 forms smaller particles (mean diameter 14.4 nm) than PTG (36.9 nm) and GM (28.3 nm) or those in control cells (29.2 nm). Both PPP1R6- and GM-derived glycogen particles are in cytosol associated with cellular structures; PTG-derived glycogen is found in membrane- and organelle-devoid cytosolic glycogen-rich areas; and glycogen particles are dispersed in the cytosol in control cells. A tagged PPP1R6 protein at the C-terminus with EGFP shows a diffuse cytosol pattern in glucose-replete and -depleted cells and a punctuate pattern surrounding the nucleus in glucose-depleted cells, which colocates with RFP tagged with the Golgi targeting domain of β-1,4-galactosyltransferase, according to a computational prediction for PPP1R6 Golgi location.
PPP1R6 exerts a powerful glycogenic effect in cultured muscle cells, more than GM and less than PTG. PPP1R6 protein translocates from a Golgi to cytosolic location in response to glucose. The molecular size and subcellular location of myotube glycogen particles is determined by the PPP1R6, PTG and GM scaffolding.
Articles from BMC Biochemistry are provided here courtesy of
BioMed Central